Effect of vortioxetine on functional capacity in patients with major depressive disorder with self-reported cognitive dysfunction

被引：0
|
作者：
Jacobson, W. [1 ]
Olsen, C. [2 ]
Mahableshwarkar, A. [3 ]
Yinzhong, C. [4 ]
Keefe, R. [5 ]
机构：
[1] Takeda Pharmaceut North Amer, Deerfield, IL USA
[2] H Lundbeck & Co AS, Brintellix Clin Sci, Copenhagen, Denmark
[3] Takeda Pharmaceut North Amer, Global Clin Sci, Deerfield, IL USA
[4] Takeda Pharmaceut North Amer, Analyt Sci, Deerfield, IL USA
[5] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30622-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.h.012
引用
收藏
页码：S460 / S460
页数：1
相关论文
共 50 条
  • [1] A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction
    Keefe, Richard S. E.
    Nomikos, George
    Zhong, Wei
    Christensen, Michael Cronquist
    Jacobson, William
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2018, 21 (05): : 442 - 447
  • [2] Efficacy of vortioxetine versus other antidepressants on cognitive dysfunction in patients with major depressive disorder
    Baune, B. T.
    Brignone, M.
    Larsen, K. G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S470 - S470
  • [3] Using self-reported vocational functioning measures to identify employed patients with impaired functional capacity in major depressive disorder
    Murthy, Naga Venkatesha
    Xu, Rengyi
    Zhong, Wei
    Harvey, Philip D.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 260 : 550 - 556
  • [4] Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder
    Jha, Manish Kumar
    Minhajuddin, Abu
    Thase, Michael E.
    Jarrett, Robin B.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2014, 167 : 37 - 43
  • [5] Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder
    McIntyre, Roger S.
    Florea, Ioana
    Tonnoir, Brigitte
    Loft, Henrik
    Lam, Raymond W.
    Christensen, Michael Cronquist
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (01) : 115 - 121
  • [6] Clinical evidence for improvement in cognitive dysfunction in patients with major depressive disorder (MDD) after treatment with vortioxetine
    Keefe, R. S. E.
    Mahableshwarkar, A. R.
    Olsen, C. K.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S402 - S403
  • [7] Migraine Predicts Self-Reported Muscle Tension in Patients With Major Depressive Disorder
    Hung, Ching-I
    Liu, Chia-Yih
    Chen, Jane-Jane
    Wang, Shuu-Jiun
    [J]. PSYCHOSOMATICS, 2008, 49 (06) : 502 - 510
  • [8] Relationship between work functioning and self-reported cognitive complaints in patients with major depressive disorder treated with desvenlafaxine
    Alonso-Prieto, Esther
    Rubino, Cristina
    Lucey, Megan
    Evans, Vanessa C.
    Tam, Edwin M.
    Woo, Cindy
    Iverson, Grant L.
    Chakrabarty, Trisha
    Yatham, Lakshmi N.
    Lam, Raymond W.
    [J]. PSYCHIATRY RESEARCH, 2019, 272 : 144 - 148
  • [9] Impact of self-reported juvenile abuse on treatment outcome in patients with major depressive disorder
    Pandina, Gahan
    Turkoz, Ibrahim
    Bossie, Cynthia
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (01) : 384 - 391
  • [10] Cognitive Dysfunction in Major Depressive Disorder: Cause and Effect
    Knight M.J.
    Aboustate N.
    Baune B.T.
    [J]. Current Behavioral Neuroscience Reports, 2018, 5 (4) : 302 - 309
12345